Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast parameters
1.5 Data validation
1.6 COVID-19 impact analysis at global level
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Ablation devices industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Technology trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Ablation Devices Industry Insights
3.1 Industry landscape, 2018 – 2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Technological advancements in ablation devices
3.2.1.3 Rising demand for minimally invasive procedures
3.2.1.4 Growing geriatric population base
3.2.2 Industry pitfalls & challenges
3.2.2.1 High risk associated with ablation procedures
3.2.2.2 Stringent regulatory approvals
3.3 Growth potential analysis
3.3.1 By technology
3.3.2 By application
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory Landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.1.1 Abbott Laboratories
4.1.2 Boston Scientific Corporation
4.1.3 Medtronic Plc
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Ablation Devices Market, By Technology
5.1 Key segment trends
5.2 Radiofrequency devices
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.3 Laser/Light ablation
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.4 Ultrasound devices
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.5 Cryoablation Devices
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
5.6 Others
5.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 6 Ablation Devices Market, By Application
6.1 Key segment trends
6.2 Cardiology
6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.3 Oncology
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.4 Ophthalmology
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.5 Gynecology
6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.6 Urology
6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.7 Cosmetic surgery
6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
6.8 Others
6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 7 Ablation Devices Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.3 Ambulatory surgical centers
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
7.4 Others
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
Chapter 8 Ablation Devices Market Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Russia
8.3.7 Poland
8.3.8 Netherlands
8.3.9 Switzerland
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Indonesia
8.4.7 Thailand
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Alcon Laboratories
9.3 AngioDynamics
9.4 AtriCure, Inc
9.5 Bausch & Lomb Incorporated
9.6 Biotronik SE & Co. KG
9.7 Boston Scientific Corporation
9.8 CONMED Corporation
9.9 Elekta AB.
9.10 Olympus Corporation
9.11 Varian
9.12 Medtronic plc
9.13 Ethicon, Inc (Johnson & Johnson)
